ghk-cu cream Our old face cream was white and only 2400mcg—now it’s blue and measured in milligrams GHK-Cu Cream | AgelessRx

Triple-hormone-receptor agonist Retatrutide for obesity: Phase 2 trial (48-week study, up to 24% weight loss) American Diabetes Association (2023) ADA Press Release: Novel agent Retatrutide results in substantial weight reduction (83rd Scientific Sessions, Phase 2 data) ADA Meeting News (2023) Phase 2 trial results: benefits of Retatrutide in obesity, type 2 diabetes, NASH (83rd ADA Scientific Sessions coverage) ClinicalTrials.gov Study of Retatrutide (LY3437943) in adults with obesity (NCT04881760

Fistula healing is another distinctive line of research

Cellular energy & mitochondrial function studies

For researchers focused on gastrointestinal conditions, the arginate salt is a clear front-runner